Related Experiment Videos
Rational drug design of multifunctional phosphoramidate substituted nucleoside analogs
T K Venkatachalam1, P A Goodman, S Qazi
1Department of Chemistry, Virology Paradigm Pharmaceuticals LLC, 2685 Patton Road, Roseville, MN 55119, USA. tvenku@ih.org
Current Pharmaceutical Design
|June 8, 2004
Summary
Researchers developed WHI-07, a novel phosphoramidate nucleoside analog, demonstrating potent, multifunctional activity against cancer, HIV, and fertility models. This drug candidate shows promise for diverse therapeutic applications.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Molecular Pharmacology
Background:
- Phosphoramidate nucleoside analogs are explored for therapeutic potential.
- Developing multifunctional agents is crucial for combating complex diseases like cancer and HIV.
Purpose of the Study:
- To review the development and evaluation of phosphoramidate nucleoside analogs.
- To present compound WHI-07, a multifunctional drug candidate derived from zidavudine.
- To elucidate the structure-activity relationships and biological pathways of WHI-07.
Main Methods:
- Rational drug design and synthesis of phosphoramidate nucleoside analogs.
- In vitro and in vivo testing in model systems for cancer, HIV, and fertility.
- Metabolic pathway analysis and structure-activity relationship (SAR) studies.
Main Results:
- Compound WHI-07, an arylphosphoramidate derivative of zidavudine, was successfully developed.
- WHI-07 exhibited potent, multifunctional activity across cancer, HIV, and fertility models.
- Experimental evidence confirmed that specific structural moieties contribute to WHI-07's multifunctionality.
Conclusions:
- Multifunctional drug design is a powerful strategy for discovering novel therapeutics.
- WHI-07 demonstrates significant potential as a drug candidate for various diseases.
- Future research will utilize gene-chip technology to identify new targets and mechanisms of action.